Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2152 (LINC02152)
- Target
- LINC02152
- Molecular classification
- Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Non-protein coding RNA
01
Overview
Long intergenic non-protein coding RNA 2152 (LINC02152) is a human long non-coding RNA (lncRNA), specifically classified as a lincRNA as it is transcribed from intergenic regions and does not code for a protein[1][3][7]. The transcript ENST00000566208 corresponds to LINC02152. While other long intergenic non-coding RNAs have been implicated in gene regulation, epigenetic control, and various disease contexts, no specific biological function, disease role, or clinical relevance has been documented for LINC02152 itself as of the latest literature and database entries[1][3][5][7]. It has not yet been reported as a therapeutic target, a biomarker, or a disease-associated RNA. LINC02152 remains poorly characterized, and further research would be necessary to define its molecular functions and any biological or clinical relevance.
- Other names
- ENST00000566208
02
Mechanism of action
Not established
03
Biological functions
Unknown (no direct functional data for LINC02152; general functions for lincRNAs include gene regulation, chromatin modulation, and acting as competing endogenous RNA, but these are not specifically established for LINC02152)
04
Disease associations
Unknown (no published disease associations as of current data; many lincRNAs are increasingly studied for potential roles in cancer and other diseases, but LINC02152 is not specifically reported in this context)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2152 (LINC02152).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2152 (LINC02152).